Saitama, Japan

Masaaki Kurihara

This inventor holds 1 USPTO granted patent. Top assignee: Lederle (Japan), Ltd.. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaaki Kurihara. Retrieved from https://idiyas.com/inventor/masaaki-kurihara-mca4tdp5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masaaki Kurihara: Innovator in Anti-Peptic Ulcer Agents

Introduction

Masaaki Kurihara is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-peptic ulcer agents. His innovative approach has led to the creation of a unique formulation that addresses a common health issue.

Latest Patents

Masaaki Kurihara holds a patent for an anti-peptic ulcer agent. This formulation comprises a powdery material that includes tocopheryl retinoate, light silicic anhydride, and an antioxidant. Additionally, it contains a low substituted hydroxypropylcellulose and polyvinylpyrrolidone, making it orally administrable. This patent showcases his commitment to advancing medical treatments.

Career Highlights

Kurihara is associated with Lederle (Japan), Ltd., where he has been instrumental in research and development. His work has focused on creating effective solutions for gastrointestinal health, demonstrating his expertise in the pharmaceutical industry. With 1 patent to his name, he has established himself as a valuable contributor to medical science.

Collaborations

Masaaki Kurihara has collaborated with Keiichiro Ohta, further enhancing his research capabilities. Their partnership has likely fostered innovative ideas and solutions in their field.

Conclusion

Masaaki Kurihara's contributions to the development of anti-peptic ulcer agents highlight his innovative spirit and dedication to improving health outcomes. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…